MCT oil (medium-chain triglycerides)
Also called: medium-chain triglycerides, MCTs, medium chain triglyceride oil
Medium-chain triglycerides are fats made of medium-chain fatty acids. MCT oil consists almost exclusively of fatty acids with 6 to 10 carbons (6:0–10:0); many trials studied C8:0 and C10:0 triglycerides.
- Category
- Fatty acid
- Forms
- MCT oil (triglycerides of C8:0 and C10:0 fatty acids); medium-long-chain triglycerides (MLCTs) are a different product
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-30
Class 1 Well studied in people. A 2015 meta-analysis identified 13 randomized controlled trials (749 adults) comparing MCTs (C8:0 and C10:0) with long-chain triglycerides. [1]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BBlood sugar and weight1 topic
CBrain, mood and sleep1 topic
XMuscles and exercise1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Body weight and body composition in healthy adults | B | A 2015 meta-analysis of 13 RCTs (749 adults) found MCTs in place of long-chain triglycerides lowered body weight by 0.51 kg and reduced waist circumference and body fat; commercial bias was detected. [1] |
| Weight and glucose-lipid markers in overweight or obesity | B | A 2024 meta-analysis found greater weight reduction with MCT-enriched than long-chain-fat diets (−1.53%), mainly with pure MCTs, and lower blood triglycerides and HOMA-IR; medium-long-chain triglyceride diets did not significantly reduce weight. [2] |
| Blood cholesterol and triglycerides | X | A 2021 meta-analysis of 7 articles reporting randomized trials found MCT oil did not change total, LDL or HDL cholesterol but slightly raised triglycerides (0.14 mmol/L). [3] |
| Cognition in mild cognitive impairment or Alzheimer's disease | C | A 2023 meta-analysis (9 publications, 10 studies) found improved general cognition with oral MCT versus placebo, but not memory, language or attention; the authors say better-characterized studies are needed before a definitive conclusion. [4] |
| Endurance exercise performance | X | A 2022 systematic review found most studies reported MCT oil did not improve exercise performance or fuel use in healthy people; the body could not use MCT-induced ketones as its primary fuel. [5] |
Main constituents: Medium-chain fatty acids (6:0–10:0) bound as triglycerides [3]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)1 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- A 2026 systematic review of 33 studies (1,100 participants; oral, gastric or enteral MCT) found gastrointestinal symptoms, especially diarrhea, abdominal pain, discomfort and nausea, were the most frequent side effects; moderate to severe reactions and dropouts were not uncommon, especially at higher doses. [6]
- An exercise-focused systematic review states that 30 g of MCTs seems to be the safe maximal dosage to minimize adverse reactions during or after exercise. [5]
- MCT oil raised total and LDL cholesterol when compared with fats made mainly of unsaturated fatty acids. [3]
Identity, quality and standardization
- Pure MCTs and medium-long-chain triglycerides (MLCTs) are distinct; in a 2024 meta-analysis only pure MCTs significantly reduced weight. [2]
Regulatory status
- US: for GRAS Notice 449 (medium chain triglycerides, for technical effects in foods), FDA ceased to evaluate the notice at the notifier's request (closed February 19, 2014). [7]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [8]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Medium-chain fatty acids (6:0–10:0), mainly C8:0 and C10:0, as triglycerides Fatty acids and lipids (medium-chain triglycerides) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming medium-chain triglycerides or MCT oil was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]
- GRAS Notice 449 (medium chain triglycerides): at the notifier's request, FDA ceased to evaluate the notice (closed February 19, 2014). [P6]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC evaluation of medium-chain triglycerides was found (IARC Monographs list of classifications, Volumes 1–142, checked 2026-10-29). [P2]
- The NTP Technical Reports index (TR-001 to TR-606) lists no report on MCT oil or medium-chain triglycerides as such (checked 2026-10-29). [P3]
- NTP TR-426 (April 1994) gave tricaprylin, described as an oil containing saturated medium-chain fatty acids, by gavage to male F344/N rats for 2 years as a vehicle comparison; corn oil, safflower oil and tricaprylin each produced dose-related increases in hyperplasia and adenoma of the exocrine pancreas. [P7]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
Supply and conservation
- No published information found in the sources checked.
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606), 2026-10-29. ntp.niehs.nih.gov
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- McKenzie KM, et al. Medium-chain triglyceride oil and blood lipids: a systematic review and meta-analysis of randomized trials. J Nutr 2021;151(10):2949-2956 (PMID 34255085), 2021-10-01. pubmed.ncbi.nlm.nih.gov
- U.S. FDA. GRAS Notice Inventory: GRN No. 449, Medium chain triglycerides, 2014-02-19. hfpappexternal.fda.gov
- National Toxicology Program. TR-426: Comparative Toxicology Studies of Corn Oil, Safflower Oil, and Tricaprylin in Male F344/N Rats as Vehicles for Gavage (April 1994), 1994-04. ntp.niehs.nih.gov
Sources
- Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet 2015;115(2):249-263 (PMID 25636220), 2015-02. pubmed.ncbi.nlm.nih.gov
- He H, et al. The impact of medium-chain triglycerides on weight loss and metabolic health in individuals with overweight or obesity: a systematic review and meta-analysis. Clin Nutr 2024;43(8):1755-1768 (PMID 38936302), 2024-08. pubmed.ncbi.nlm.nih.gov
- McKenzie KM, et al. Medium-chain triglyceride oil and blood lipids: a systematic review and meta-analysis of randomized trials. J Nutr 2021;151(10):2949-2956 (PMID 34255085), 2021-10-01. pubmed.ncbi.nlm.nih.gov
- Sun L, et al. The effects of medium chain triglyceride for Alzheimer's disease related cognitive impairment: a systematic review and meta-analysis. J Alzheimers Dis 2023;94(2):441-456 (PMID 37248908), 2023. pubmed.ncbi.nlm.nih.gov
- Chapman-Lopez TJ, Koh Y. The effects of medium-chain triglyceride oil supplementation on endurance performance and substrate utilization in healthy populations: a systematic review. J Obes Metab Syndr 2022;31(3):217-229 (PMID 36096496), 2022-09-30. pubmed.ncbi.nlm.nih.gov
- Scheller M, et al. Gastrointestinal issues predominate among side effects of medium-chain triglyceride consumption in humans. Front Nutr 2026;13:1829954 (PMID 42688103), 2026-08-19. pubmed.ncbi.nlm.nih.gov
- U.S. FDA. GRAS Notice Inventory: GRN No. 449, Medium chain triglycerides, 2014-02-19. hfpappexternal.fda.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in fatty acid: Algal oil (DHA and EPA) · Arachidonic acid · Argan oil · Conjugated linoleic acid (CLA) · Evening primrose oil · GLA oils (borage and blackcurrant seed oil) · Krill oil · Linoleic acid · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.